NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|153945794|ref|NP_808809|]
View 

Eef1akmt4-Ece2 readthrough isoform b [Mus musculus]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
230-879 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 819.30  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 230 VSPCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLLENTTFNSS-SEAERKTRSFYLSCLQSERIEKLGA 308
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAAdSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 309 KPLRDLIDKIGGWnitgPWDEDSFMDVLKAVAGTYRATPFFTVYVSADSKSSNSNIIQVDQSGLFLPSRDYYLNrTANEK 388
Cdd:cd08662   81 KPLKPLLDKIGGL----PSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLD-EENAE 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 389 VLTAYLDYMVELGVLLGGQPTSTREQMQQVLELEIQLANITVPQDQRRDEEKIYHKMSISELQALAPAVDWLEFLSFLLS 468
Cdd:cd08662  156 IREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYLKALGP 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 469 PLElgDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQRFETAQEKLLETLYGTKKScTPRWQTCIS 548
Cdd:cd08662  236 PAD--DPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEP-EPRWKRCVE 312
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 549 NTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVWMDEKTRLAAKEKADAIYDMIGFPDFILEPKELD 628
Cdd:cd08662  313 LVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRDYSALD 392
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 629 DVYDGYEVSeDSFFQNMLNLYNFSAKVMADQLRKPPSRDQWSMTPQTVNAYYLPTKNEIVFPAGILQAPFYAHNHPKALN 708
Cdd:cd08662  393 IYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALN 471
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 709 FGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLTAFQNHTACMEEQYSQYQVN-GERLNGLQTLGENIADNGGLK 787
Cdd:cd08662  472 YGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPpGLHVNGKLTLGENIADNGGLR 551
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 788 AAYNAYKAWLRKHGEEQPlPAVGLTNHQLFFVGFAQVWCSVRTPESSHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCP 867
Cdd:cd08662  552 LAYRAYKKWLKENGPELP-GLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCP 630
                        650
                 ....*....|..
gi 153945794 868 VGSPMNPGQLCE 879
Cdd:cd08662  631 PGSPMNPEKKCR 642
UbiG COG2227
2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase [Coenzyme transport and ...
46-128 2.53e-11

2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase [Coenzyme transport and metabolism]; 2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase is part of the Pathway/BioSystem: Ubiquinone biosynthesis


:

Pssm-ID: 441829 [Multi-domain]  Cd Length: 126  Bit Score: 61.57  E-value: 2.53e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  46 ASFRALLEPELCPEDRILVLGCGNSALSYELFLGGFpNVTSVDYSPVVVAAMQVRYAHVPsLRWETMDVRALDFPSGSFD 125
Cdd:COG2227   12 RRLAALLARLLPAGGRVLDVGCGTGRLALALARRGA-DVTGVDISPEALEIARERAAELN-VDFVQGDLEDLPLEDGSFD 89

                 ...
gi 153945794 126 VVL 128
Cdd:COG2227   90 LVI 92
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
230-879 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 819.30  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 230 VSPCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLLENTTFNSS-SEAERKTRSFYLSCLQSERIEKLGA 308
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAAdSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 309 KPLRDLIDKIGGWnitgPWDEDSFMDVLKAVAGTYRATPFFTVYVSADSKSSNSNIIQVDQSGLFLPSRDYYLNrTANEK 388
Cdd:cd08662   81 KPLKPLLDKIGGL----PSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLD-EENAE 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 389 VLTAYLDYMVELGVLLGGQPTSTREQMQQVLELEIQLANITVPQDQRRDEEKIYHKMSISELQALAPAVDWLEFLSFLLS 468
Cdd:cd08662  156 IREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYLKALGP 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 469 PLElgDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQRFETAQEKLLETLYGTKKScTPRWQTCIS 548
Cdd:cd08662  236 PAD--DPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEP-EPRWKRCVE 312
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 549 NTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVWMDEKTRLAAKEKADAIYDMIGFPDFILEPKELD 628
Cdd:cd08662  313 LVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRDYSALD 392
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 629 DVYDGYEVSeDSFFQNMLNLYNFSAKVMADQLRKPPSRDQWSMTPQTVNAYYLPTKNEIVFPAGILQAPFYAHNHPKALN 708
Cdd:cd08662  393 IYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALN 471
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 709 FGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLTAFQNHTACMEEQYSQYQVN-GERLNGLQTLGENIADNGGLK 787
Cdd:cd08662  472 YGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPpGLHVNGKLTLGENIADNGGLR 551
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 788 AAYNAYKAWLRKHGEEQPlPAVGLTNHQLFFVGFAQVWCSVRTPESSHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCP 867
Cdd:cd08662  552 LAYRAYKKWLKENGPELP-GLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCP 630
                        650
                 ....*....|..
gi 153945794 868 VGSPMNPGQLCE 879
Cdd:cd08662  631 PGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
206-881 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 661.85  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 206 AHSTCVTEACIRVAGKILESLDRGVSPCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLLE---NTTFNS 282
Cdd:COG3590   13 ALAACAAAAAAGTSGIDLANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEeaaAAPAAA 92
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 283 SSEaERKTRSFYLSCLQSERIEKLGAKPLRDLIDKIGGwnITgpwdedSFMDVLKAVAGTYRA--TPFFTVYVSADSKSS 360
Cdd:COG3590   93 GSD-EQKIGDLYASFMDEAAIEALGLAPLKPDLARIDA--IK------DKADLAALLAALHRAgvGGLFGFGVDADLKNS 163
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 361 NSNIIQVDQSGLFLPSRDYYLNRTA-NEKVLTAYLDYMVELGVLLGGQPTSTREQMQQVLELEIQLANITVPQDQRRDEE 439
Cdd:COG3590  164 TRYIAYLGQGGLGLPDRDYYLKDDEkSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELRDPE 243
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 440 KIYHKMSISELQALAPAVDWLEFLSfllsPLELGDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQ 519
Cdd:COG3590  244 KTYNPMTVAELAKLAPGFDWDAYLK----ALGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSK 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 520 RFETAQ----EKlleTLYGTKKScTPRWQTCISNTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVW 595
Cdd:COG3590  320 AFVDANfdfyGK---TLSGQKEQ-RPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDW 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 596 MDEKTRLAAKEKADAIYDMIGFPDfilepKELDdvYDGYEVSEDSFFQNMLNLYNFSAKVMADQLRKPPSRDQWSMTPQT 675
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIGYPD-----KWRD--YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQT 468
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 676 VNAYYLPTKNEIVFPAGILQAPFYAHNHPKALNFGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLTAFQNHTAC 755
Cdd:COG3590  469 VNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKK 548
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 756 MEEQYSQYQV-NGERLNGLQTLGENIADNGGLKAAYNAYKAWLrkhgEEQPLPAV-GLTNHQLFFVGFAQVWCSVRTPES 833
Cdd:COG3590  549 LVAQYDAYEPlPGLHVNGKLTLGENIADLGGLSIAYDAYKLSL----KGKEAPVIdGFTGDQRFFLGWAQVWRSKARDEA 624
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|
gi 153945794 834 SHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCPVGSPM--NPGQLCEVW 881
Cdd:COG3590  625 LRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
232-618 3.01e-154

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 457.53  E-value: 3.01e-154
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  232 PCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLL-ENTTFNSSSEAERKTRSFYLSCLQSERIEKLGAKP 310
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILeEAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  311 LRDLIDKIGGWNITgpWDEDSFMDVLKAVAgTYRATPFFTVYVSADSKSSNSNIIQVDQSGLFLPSRDYYLNRT--ANEK 388
Cdd:pfam05649  81 LKPLLDEIGGPLAN--KDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLKDRdeKSAE 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  389 VLTAYLDYMVELGVLLGGQPTStREQMQQVLELEIQLANITVPQDQRRDEEKIYHKMSISELQALAPAVDWLEFLSFLLs 468
Cdd:pfam05649 158 IREAYKAYIAKLLTLLGASEEA-AALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLAPGIDWKAYLNAAG- 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  469 pLELGDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQRFETAQEKLLETLYGTKKSctPRWQTCIS 548
Cdd:pfam05649 236 -LPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSGTKQR--PRWKRCVS 312
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  549 NTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVWMDEKTRLAAKEKADAIYDMIGFP 618
Cdd:pfam05649 313 LVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
UbiG COG2227
2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase [Coenzyme transport and ...
46-128 2.53e-11

2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase [Coenzyme transport and metabolism]; 2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase is part of the Pathway/BioSystem: Ubiquinone biosynthesis


Pssm-ID: 441829 [Multi-domain]  Cd Length: 126  Bit Score: 61.57  E-value: 2.53e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  46 ASFRALLEPELCPEDRILVLGCGNSALSYELFLGGFpNVTSVDYSPVVVAAMQVRYAHVPsLRWETMDVRALDFPSGSFD 125
Cdd:COG2227   12 RRLAALLARLLPAGGRVLDVGCGTGRLALALARRGA-DVTGVDISPEALEIARERAAELN-VDFVQGDLEDLPLEDGSFD 89

                 ...
gi 153945794 126 VVL 128
Cdd:COG2227   90 LVI 92
Methyltransf_25 pfam13649
Methyltransferase domain; This family appears to be a methyltransferase domain.
62-128 4.11e-09

Methyltransferase domain; This family appears to be a methyltransferase domain.


Pssm-ID: 463945 [Multi-domain]  Cd Length: 96  Bit Score: 54.49  E-value: 4.11e-09
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 153945794   62 ILVLGCGNSALSYELFLGGFPNVTSVDYSPVVVAAMQVRYA-HVPSLRWETMDVRALDFPSGSFDVVL 128
Cdd:pfam13649   1 VLDLGCGTGRLTLALARRGGARVTGVDLSPEMLERARERAAeAGLNVEFVQGDAEDLPFPDGSFDLVV 68
AdoMet_MTases cd02440
S-adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase), class I; ...
61-135 6.26e-08

S-adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase), class I; AdoMet-MTases are enzymes that use S-adenosyl-L-methionine (SAM or AdoMet) as a substrate for methyltransfer, creating the product S-adenosyl-L-homocysteine (AdoHcy). There are at least five structurally distinct families of AdoMet-MTases, class I being the largest and most diverse. Within this class enzymes can be classified by different substrate specificities (small molecules, lipids, nucleic acids, etc.) and different target atoms for methylation (nitrogen, oxygen, carbon, sulfur, etc.).


Pssm-ID: 100107 [Multi-domain]  Cd Length: 107  Bit Score: 51.66  E-value: 6.26e-08
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 153945794  61 RILVLGCGNSALSYELFLGGFPNVTSVDYSPVVVAAMQ--VRYAHVPSLRWETMDVRALDF-PSGSFDVVLEKGTLDA 135
Cdd:cd02440    1 RVLDLGCGTGALALALASGPGARVTGVDISPVALELARkaAAALLADNVEVLKGDAEELPPeADESFDVIISDPPLHH 78
PRK08317 PRK08317
hypothetical protein; Provisional
44-161 2.83e-04

hypothetical protein; Provisional


Pssm-ID: 181382 [Multi-domain]  Cd Length: 241  Bit Score: 43.39  E-value: 2.83e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  44 DFASFRA----LLEPElcPEDRILVLGCGNSALSYEL--FLGGFPNVTSVDYSPVVVAAMQVR-YAHVPSLRWETMDVRA 116
Cdd:PRK08317   3 DFRRYRArtfeLLAVQ--PGDRVLDVGCGPGNDARELarRVGPEGRVVGIDRSEAMLALAKERaAGLGPNVEFVRGDADG 80
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....*
gi 153945794 117 LDFPSGSFDVVLEKGTLdamlagepdpwnvssEGVHTVDQVLSEV 161
Cdd:PRK08317  81 LPFPDGSFDAVRSDRVL---------------QHLEDPARALAEI 110
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
230-879 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 819.30  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 230 VSPCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLLENTTFNSS-SEAERKTRSFYLSCLQSERIEKLGA 308
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAAdSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 309 KPLRDLIDKIGGWnitgPWDEDSFMDVLKAVAGTYRATPFFTVYVSADSKSSNSNIIQVDQSGLFLPSRDYYLNrTANEK 388
Cdd:cd08662   81 KPLKPLLDKIGGL----PSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLD-EENAE 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 389 VLTAYLDYMVELGVLLGGQPTSTREQMQQVLELEIQLANITVPQDQRRDEEKIYHKMSISELQALAPAVDWLEFLSFLLS 468
Cdd:cd08662  156 IREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYLKALGP 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 469 PLElgDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQRFETAQEKLLETLYGTKKScTPRWQTCIS 548
Cdd:cd08662  236 PAD--DPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEP-EPRWKRCVE 312
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 549 NTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVWMDEKTRLAAKEKADAIYDMIGFPDFILEPKELD 628
Cdd:cd08662  313 LVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRDYSALD 392
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 629 DVYDGYEVSeDSFFQNMLNLYNFSAKVMADQLRKPPSRDQWSMTPQTVNAYYLPTKNEIVFPAGILQAPFYAHNHPKALN 708
Cdd:cd08662  393 IYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALN 471
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 709 FGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLTAFQNHTACMEEQYSQYQVN-GERLNGLQTLGENIADNGGLK 787
Cdd:cd08662  472 YGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPpGLHVNGKLTLGENIADNGGLR 551
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 788 AAYNAYKAWLRKHGEEQPlPAVGLTNHQLFFVGFAQVWCSVRTPESSHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCP 867
Cdd:cd08662  552 LAYRAYKKWLKENGPELP-GLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCP 630
                        650
                 ....*....|..
gi 153945794 868 VGSPMNPGQLCE 879
Cdd:cd08662  631 PGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
206-881 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 661.85  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 206 AHSTCVTEACIRVAGKILESLDRGVSPCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLLE---NTTFNS 282
Cdd:COG3590   13 ALAACAAAAAAGTSGIDLANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEeaaAAPAAA 92
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 283 SSEaERKTRSFYLSCLQSERIEKLGAKPLRDLIDKIGGwnITgpwdedSFMDVLKAVAGTYRA--TPFFTVYVSADSKSS 360
Cdd:COG3590   93 GSD-EQKIGDLYASFMDEAAIEALGLAPLKPDLARIDA--IK------DKADLAALLAALHRAgvGGLFGFGVDADLKNS 163
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 361 NSNIIQVDQSGLFLPSRDYYLNRTA-NEKVLTAYLDYMVELGVLLGGQPTSTREQMQQVLELEIQLANITVPQDQRRDEE 439
Cdd:COG3590  164 TRYIAYLGQGGLGLPDRDYYLKDDEkSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELRDPE 243
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 440 KIYHKMSISELQALAPAVDWLEFLSfllsPLELGDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQ 519
Cdd:COG3590  244 KTYNPMTVAELAKLAPGFDWDAYLK----ALGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSK 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 520 RFETAQ----EKlleTLYGTKKScTPRWQTCISNTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVW 595
Cdd:COG3590  320 AFVDANfdfyGK---TLSGQKEQ-RPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDW 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 596 MDEKTRLAAKEKADAIYDMIGFPDfilepKELDdvYDGYEVSEDSFFQNMLNLYNFSAKVMADQLRKPPSRDQWSMTPQT 675
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIGYPD-----KWRD--YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQT 468
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 676 VNAYYLPTKNEIVFPAGILQAPFYAHNHPKALNFGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLTAFQNHTAC 755
Cdd:COG3590  469 VNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKK 548
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 756 MEEQYSQYQV-NGERLNGLQTLGENIADNGGLKAAYNAYKAWLrkhgEEQPLPAV-GLTNHQLFFVGFAQVWCSVRTPES 833
Cdd:COG3590  549 LVAQYDAYEPlPGLHVNGKLTLGENIADLGGLSIAYDAYKLSL----KGKEAPVIdGFTGDQRFFLGWAQVWRSKARDEA 624
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|
gi 153945794 834 SHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCPVGSPM--NPGQLCEVW 881
Cdd:COG3590  625 LRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
232-618 3.01e-154

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 457.53  E-value: 3.01e-154
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  232 PCQDFYQFSCGGWIRRNPLPNGRSRWNTFNSLWDQNQAILKHLL-ENTTFNSSSEAERKTRSFYLSCLQSERIEKLGAKP 310
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILeEAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  311 LRDLIDKIGGWNITgpWDEDSFMDVLKAVAgTYRATPFFTVYVSADSKSSNSNIIQVDQSGLFLPSRDYYLNRT--ANEK 388
Cdd:pfam05649  81 LKPLLDEIGGPLAN--KDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLKDRdeKSAE 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  389 VLTAYLDYMVELGVLLGGQPTStREQMQQVLELEIQLANITVPQDQRRDEEKIYHKMSISELQALAPAVDWLEFLSFLLs 468
Cdd:pfam05649 158 IREAYKAYIAKLLTLLGASEEA-AALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLAPGIDWKAYLNAAG- 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  469 pLELGDSEPVVVYGTEYLQQVSELINRTEPSILNNYLIWNLVQKTTSSLDQRFETAQEKLLETLYGTKKSctPRWQTCIS 548
Cdd:pfam05649 236 -LPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSGTKQR--PRWKRCVS 312
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  549 NTDDALGFALGSLFVKATFDRQSKEIAEGMINEIRSAFEETLGDLVWMDEKTRLAAKEKADAIYDMIGFP 618
Cdd:pfam05649 313 LVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
677-880 7.65e-80

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 256.57  E-value: 7.65e-80
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  677 NAYYLPTKNEIVFPAGILQAPFYAHNHPKALNFGGIGVVMGHELTHAFDDQGREYDKEGNLRPWWQNESLTAFQNHTACM 756
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  757 EEQYSQY--QVNGERLNGLQTLGENIADNGGLKAAYNAYKAwlRKHGEEQPLPAV-GLTNHQLFFVGFAQVWCSVRTPES 833
Cdd:pfam01431  81 IEQYSEYtpPDGTKCANGTLTLGENIADLGGLTIALRAYKK--LLSANETVLPGFeNLTPDQLFFRGAAQIWCMKQSPAE 158
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*..
gi 153945794  834 SHEGLVTDPHSPARFRVLGTLSNSRDFLRHFGCPVGSPMNPGQLCEV 880
Cdd:pfam01431 159 VLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
UbiG COG2227
2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase [Coenzyme transport and ...
46-128 2.53e-11

2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase [Coenzyme transport and metabolism]; 2-polyprenyl-3-methyl-5-hydroxy-6-metoxy-1,4-benzoquinol methylase is part of the Pathway/BioSystem: Ubiquinone biosynthesis


Pssm-ID: 441829 [Multi-domain]  Cd Length: 126  Bit Score: 61.57  E-value: 2.53e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  46 ASFRALLEPELCPEDRILVLGCGNSALSYELFLGGFpNVTSVDYSPVVVAAMQVRYAHVPsLRWETMDVRALDFPSGSFD 125
Cdd:COG2227   12 RRLAALLARLLPAGGRVLDVGCGTGRLALALARRGA-DVTGVDISPEALEIARERAAELN-VDFVQGDLEDLPLEDGSFD 89

                 ...
gi 153945794 126 VVL 128
Cdd:COG2227   90 LVI 92
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
579-753 2.18e-09

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 55.57  E-value: 2.18e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 579 INEIRSAFEETLGdlvwmdektRLAAKEKADAIYDMIGFPDFIlepkelddvydgyevsedsffqnmlnlynfsakvmad 658
Cdd:cd09594    4 AHETYKYYEELLG---------RTSFRYPVSPIYSLLVYPAYV------------------------------------- 37
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794 659 qlrkppsrdqwsmTPQTVNAYYLPTkNEIVFPAGILQApfyahnhpkalnFGGIGVVMGHELTHAFDDQGREYDkegnlr 738
Cdd:cd09594   38 -------------EVNAYNAMWIPS-TNIFYGAGILDT------------LSGTIDVLAHELTHAFTGQFSNLM------ 85
                        170
                 ....*....|....*
gi 153945794 739 pwWQNESLTAFQNHT 753
Cdd:cd09594   86 --YSWSSGWLNEGIS 98
Methyltransf_25 pfam13649
Methyltransferase domain; This family appears to be a methyltransferase domain.
62-128 4.11e-09

Methyltransferase domain; This family appears to be a methyltransferase domain.


Pssm-ID: 463945 [Multi-domain]  Cd Length: 96  Bit Score: 54.49  E-value: 4.11e-09
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 153945794   62 ILVLGCGNSALSYELFLGGFPNVTSVDYSPVVVAAMQVRYA-HVPSLRWETMDVRALDFPSGSFDVVL 128
Cdd:pfam13649   1 VLDLGCGTGRLTLALARRGGARVTGVDLSPEMLERARERAAeAGLNVEFVQGDAEDLPFPDGSFDLVV 68
Tam COG4106
Trans-aconitate methyltransferase [Energy production and conversion];
58-128 7.74e-09

Trans-aconitate methyltransferase [Energy production and conversion];


Pssm-ID: 443282 [Multi-domain]  Cd Length: 100  Bit Score: 53.67  E-value: 7.74e-09
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 153945794  58 PEDRILVLGCGNSALSyELFLGGFPN--VTSVDYSPVVVAAMQvryAHVPSLRWETMDVRALDFPsGSFDVVL 128
Cdd:COG4106    1 PPRRVLDLGCGTGRLT-ALLAERFPGarVTGVDLSPEMLARAR---ARLPNVRFVVADLRDLDPP-EPFDLVV 68
UbiE COG2226
Ubiquinone/menaquinone biosynthesis C-methylase UbiE/MenG [Coenzyme transport and metabolism]; ...
40-128 1.21e-08

Ubiquinone/menaquinone biosynthesis C-methylase UbiE/MenG [Coenzyme transport and metabolism]; Ubiquinone/menaquinone biosynthesis C-methylase UbiE/MenG is part of the Pathway/BioSystem: Biotin biosynthesis


Pssm-ID: 441828 [Multi-domain]  Cd Length: 143  Bit Score: 54.61  E-value: 1.21e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  40 EWFGDFASFRALLEP-ELCPEDRILVLGCGNSALSYELFLGGFpNVTSVDYSPVVVA-AMQVRYAHVPSLRWETMDVRAL 117
Cdd:COG2226    3 RVAARYDGREALLAAlGLRPGARVLDLGCGTGRLALALAERGA-RVTGVDISPEMLElARERAAEAGLNVEFVVGDAEDL 81
                         90
                 ....*....|.
gi 153945794 118 DFPSGSFDVVL 128
Cdd:COG2226   82 PFPDGSFDLVI 92
AdoMet_MTases cd02440
S-adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase), class I; ...
61-135 6.26e-08

S-adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase), class I; AdoMet-MTases are enzymes that use S-adenosyl-L-methionine (SAM or AdoMet) as a substrate for methyltransfer, creating the product S-adenosyl-L-homocysteine (AdoHcy). There are at least five structurally distinct families of AdoMet-MTases, class I being the largest and most diverse. Within this class enzymes can be classified by different substrate specificities (small molecules, lipids, nucleic acids, etc.) and different target atoms for methylation (nitrogen, oxygen, carbon, sulfur, etc.).


Pssm-ID: 100107 [Multi-domain]  Cd Length: 107  Bit Score: 51.66  E-value: 6.26e-08
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 153945794  61 RILVLGCGNSALSYELFLGGFPNVTSVDYSPVVVAAMQ--VRYAHVPSLRWETMDVRALDF-PSGSFDVVLEKGTLDA 135
Cdd:cd02440    1 RVLDLGCGTGALALALASGPGARVTGVDISPVALELARkaAAALLADNVEVLKGDAEELPPeADESFDVIISDPPLHH 78
Methyltransf_11 pfam08241
Methyltransferase domain; Members of this family are SAM dependent methyltransferases.
63-128 1.22e-07

Methyltransferase domain; Members of this family are SAM dependent methyltransferases.


Pssm-ID: 462406 [Multi-domain]  Cd Length: 94  Bit Score: 50.36  E-value: 1.22e-07
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 153945794   63 LVLGCGNSALSYELFLGGfPNVTSVDYSPVVVAAMQVRYAHVPsLRWETMDVRALDFPSGSFDVVL 128
Cdd:pfam08241   1 LDVGCGTGLLTELLARLG-ARVTGVDISPEMLELAREKAPREG-LTFVVGDAEDLPFPDNSFDLVL 64
PRK08317 PRK08317
hypothetical protein; Provisional
44-161 2.83e-04

hypothetical protein; Provisional


Pssm-ID: 181382 [Multi-domain]  Cd Length: 241  Bit Score: 43.39  E-value: 2.83e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  44 DFASFRA----LLEPElcPEDRILVLGCGNSALSYEL--FLGGFPNVTSVDYSPVVVAAMQVR-YAHVPSLRWETMDVRA 116
Cdd:PRK08317   3 DFRRYRArtfeLLAVQ--PGDRVLDVGCGPGNDARELarRVGPEGRVVGIDRSEAMLALAKERaAGLGPNVEFVRGDADG 80
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....*
gi 153945794 117 LDFPSGSFDVVLEKGTLdamlagepdpwnvssEGVHTVDQVLSEV 161
Cdd:PRK08317  81 LPFPDGSFDAVRSDRVL---------------QHLEDPARALAEI 110
SmtA COG0500
SAM-dependent methyltransferase [Secondary metabolites biosynthesis, transport and catabolism, ...
25-128 5.43e-04

SAM-dependent methyltransferase [Secondary metabolites biosynthesis, transport and catabolism, General function prediction only];


Pssm-ID: 440266 [Multi-domain]  Cd Length: 199  Bit Score: 42.21  E-value: 5.43e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  25 YWDQRYKDAADSGpyewfgdFASFRALLePELCPEDRILVLGCGNSALSYELFLGGFPNVTSVDYSPVVVAAMQVRY--A 102
Cdd:COG0500    1 PWDSYYSDELLPG-------LAALLALL-ERLPKGGRVLDLGCGTGRNLLALAARFGGRVIGIDLSPEAIALARARAakA 72
                         90       100
                 ....*....|....*....|....*..
gi 153945794 103 HVPSLRWETMDV-RALDFPSGSFDVVL 128
Cdd:COG0500   73 GLGNVEFLVADLaELDPLPAESFDLVV 99
Methyltransf_31 pfam13847
Methyltransferase domain; This family appears to have methyltransferase activity.
61-136 7.02e-04

Methyltransferase domain; This family appears to have methyltransferase activity.


Pssm-ID: 463998 [Multi-domain]  Cd Length: 150  Bit Score: 40.86  E-value: 7.02e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794   61 RILVLGCGNSALSYELFLGGFPN--VTSVDYSPVVVAAMQVRYAHVPS--LRWETMDVRALD--FPSGSFDVVLEKGTLD 134
Cdd:pfam13847   6 RVLDLGCGTGHLSFELAEELGPNaeVVGIDISEEAIEKARENAQKLGFdnVEFEQGDIEELPelLEDDKFDVVISNCVLN 85

                  ..
gi 153945794  135 AM 136
Cdd:pfam13847  86 HI 87
Methyltransf_12 pfam08242
Methyltransferase domain; Members of this family are SAM dependent methyltransferases.
63-136 7.71e-04

Methyltransferase domain; Members of this family are SAM dependent methyltransferases.


Pssm-ID: 400515 [Multi-domain]  Cd Length: 98  Bit Score: 39.66  E-value: 7.71e-04
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 153945794   63 LVLGCGNSALSYELF-LGGFPNVTSVDYSPVVVAAMQVRYAHVPSLRWETMDVRALD---FPSGSFDVVLEKGTLDAM 136
Cdd:pfam08242   1 LEIGCGTGTLLRALLeALPGLEYTGLDISPAALEAARERLAALGLLNAVRVELFQLDlgeLDPGSFDVVVASNVLHHL 78
Cfa COG2230
Cyclopropane fatty-acyl-phospholipid synthase and related methyltransferases [Lipid transport ...
55-128 4.87e-03

Cyclopropane fatty-acyl-phospholipid synthase and related methyltransferases [Lipid transport and metabolism];


Pssm-ID: 441831 [Multi-domain]  Cd Length: 158  Bit Score: 38.76  E-value: 4.87e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 153945794  55 ELCPEDRILVLGCGNSALSyeLFL---GGFpNVTSVDYSPVVVAAMQ--VRYAHVP-SLRWETMDVRALDFPsGSFDVVL 128
Cdd:COG2230   48 GLKPGMRVLDIGCGWGGLA--LYLarrYGV-RVTGVTLSPEQLEYARerAAEAGLAdRVEVRLADYRDLPAD-GQFDAIV 123
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH